Vol 6, No 4 (2005): Practical Diabetology
Other materials agreed with the Editors
Published online: 2005-08-23
The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy. Initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial
Diabetologia Praktyczna 2005;6(4):210-222.
Abstract
Not available
Keywords: diabetic retinopathyvisual lossruboxistaurin